| Rene L Wells, PA-C | |
|
90 Beaver Dr Bldg C, Du Bois, PA 15801-2440 | |
| (814) 317-2273 | |
| Not Available |
| Full Name | Rene L Wells |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 90 Beaver Dr Bldg C, Du Bois, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104991777 | NPI | - | NPPES |
| 0018251700002 | Medicaid | PA | |
| 2078210 | Other | PA | BLUE SHIELD |
| V0075D | Other | PA | UPMC |
| 61854 | Other | PA | GEISINGER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OA002592 (Pennsylvania) | Secondary |
| 363A00000X | Physician Assistant | MA051791 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rene L Wells, PA-C 90 Beaver Dr Bldg C, Du Bois, PA 15801-2440 Ph: (814) 317-2273 | Rene L Wells, PA-C 90 Beaver Dr Bldg C, Du Bois, PA 15801-2440 Ph: (814) 317-2273 |
News Archive
A vast majority (82 percent) of our nation's middle-income Americans on Medicare say that they are extremely or very satisfied with Medicare's access and quality of healthcare, according to a new study conducted by the Bankers Life and Casualty Company Center for a Secure Retirement.
Having patients lie on their left side while the right side of their colon is being examined can result in more polyps being found, thus increasing the effectiveness of colonoscopy for colorectal cancer (CRC) screening, according to a study in the September issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).
Members of the Health Sciences Association, the health care union that represents health sciences professionals who deliver diagnosis, treatment and recovery in BC's hospitals and communities, is meeting this weekend at its 39th annual convention in Vancouver.
A new action plan announced today by Novo Nordisk and collaborative partners at the Diabetes UK conference has identified improved self-management, structured education and psychological support as key priorities for diabetes care in the UK.
Alize Pharma, a company specialized in the development of drugs for the treatment of metabolic diseases and rare diseases, announces today the launch of the first Phase I clinical trial for AZP-531, its unacylated ghrelin analog, in type 2 diabetes.
› Verified 3 days ago